SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote (148)1/7/1997 2:04:00 PM
From: Clive Roberts   of 6136
 
There was more today on their intention to make Viracept available to children, and was a lead story in the Interactive Wall Street Journal, with some great comments from doctors excited about the news.

eg

The giveaway program is "great news" because "I have a waiting list," said Andrew Wiznia, director of the pediatric HIV program at Bronx Lebanon Hospital in New York. Dr. Wiznia has treated 12 children with Viracept during the past three months. "This is a real good drug, it may be a great drug, we don't know. It seems to be well tolerated by children taking it," and "only occasionally do kids say 'yucky,' " he said.

Parents with children in the study were "ecstatic," Dr. Wiznia said. "We've had parents come in and say it was like a light bulb went on in the child. Within one or two weeks of starting therapy, some children are showing dramatic changes, going from apathetic to interactive."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext